Cerebrovascular Disease

  • Melvina L. McCabe


Stroke is the third leading cause of death in the United States.1 The physical and emotional disability suffered after a stroke is significant, and the financial burden is tremendous. Direct costs, which include prevention, detection, and treatment for stroke, were estimated at $3.26 billion in 1976.2 For these reasons it is important for family physicians to know the risk factors for stroke that might predispose a patient, to implement a plan to prevent the development of the risk factors, to employ the most efficient method of evaluating someone with symptoms suggestive of a stroke, and to be aware of the management issues.


Internal Carotid Artery Middle Cerebral Artery Subarachnoid Hemorrhage Intracerebral Hemorrhage Carotid Endarterectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Monthly Vital Statistics Report. Births, Marriages, Divorces & Deaths for 1989. 1989;38(5):1–14.Google Scholar
  2. 2.
    Adelman SM. Economic impact. Natl Surv Stroke 1981; 12 Suppl 1:169–78.Google Scholar
  3. 3.
    McDowell F, Caplan L. Cerebrovascular survey report 1985. National Institutes of Health, Washington, DC 1985:1–209.Google Scholar
  4. 4.
    Robins M, Baum H. Incidence. Natl Surv Stroke 1981;12 Suppl 1:145–55.Google Scholar
  5. 5.
    Gillum R. Stroke in blacks. Stroke 1988;19(l):1–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Wolf P, Kannel W, Verter J. Current status of risk factors for stroke. Neurol Clin 1983; 1:317–43.PubMedGoogle Scholar
  7. 7.
    Kannel W, Wolf P, Verter J, McNamara P. Epidemiologic assessment of the role of blood pressure in stroke—the Framingham Study. JAMA 1970;214:301–10.PubMedCrossRefGoogle Scholar
  8. 8.
    Baum H, Robins M. Survival and prevalence. Stroke 1981; 12 Suppl 1:159–68.Google Scholar
  9. 9.
    Garraway WM, Whisnant JP, Furlan A, Phillips LH, Kurland LT, O’Fallon M. The declining incidence of stroke. N Engl J Med 1979;300:440–52.CrossRefGoogle Scholar
  10. 10.
    Broderick J, Phillips S, Whisnant J, O’Fallon WM, Bergstralh E. Incidence rates of stroke in the eighties: the end of the decline in stroke. Stroke 1989;20:577–82.PubMedCrossRefGoogle Scholar
  11. 11.
    Whisnant J. The decline of stroke. Stroke 1984;15:160–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Colandrea M, Friedman G, Nichaman M, Lynd C. Systolic hypertension in the elderly. Geriatrics 1970;41:239–45.Google Scholar
  13. 13.
    Garland C, Barret-Connor E, Suarez L, Criqui M. Isolated systolic hypertension and mortality after age 60 years. Am J Epidemiol 1983;118:365–76.PubMedGoogle Scholar
  14. 14.
    Kannel W, Wolf PA, McGee D, Dawber T, McNamara P, Castelli W Systolic blood pressure, arterial rigidity and risk of stroke—the Framingham study. JAMA 1981;245:1225–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Hulley S, Furberg CD, Gurland B, et al. Systolic hypertension in the elderly program (SHEP): antihypertensive efficacy of chlorthalidone. Am J Cardiol 1985;56:913–20.PubMedCrossRefGoogle Scholar
  16. 16.
    Whisnant J. Epidemiology of stroke: emphasis on transient cerebral ischemic attacks and hypertension. Stroke 1974;5:68–70.PubMedCrossRefGoogle Scholar
  17. 17.
    Dyken M, Wolf P, Barnett HJM, et al. Risk factors in stroke. Stroke 1984;15:1105–11.CrossRefGoogle Scholar
  18. 18.
    Thompson P, Robinson J. Stroke after acute myocardial infarction: relation to infarct size. BMJ 1978;2:457–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Wolf P, Dawber T, Thomas E, Kannel W Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978;28:973–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Millikan C, McDowell F, Easton JD. Stroke. Philadelphia: Lea & Febiger, 1987.Google Scholar
  21. 21.
    Kannel W, Gordon T, Wolf P, McNamara P. Hemoglobin and the risk of cerebral infarction: the Framingham study. Stroke 1972;3:409–19.PubMedCrossRefGoogle Scholar
  22. 22.
    Stehbens WE. Pathology of cerebral blood vessels. St. Louis: Mosby, 1972:189–91.Google Scholar
  23. 23.
    Hennerici M, Hulsbomer HB, Rautenberg W, Hefter H. Spontaneous history of asymptomatic internal carotid occlusion. Stroke 1986;17:718–22.PubMedCrossRefGoogle Scholar
  24. 24.
    Fischer CM, Gore I, Okabe N, White PD. Atherosclerosis of the carotid and vertebral arteries—extracranial and intracranial. In: Proceedings of the American Association of Neuropathologists; Atlantic City, NJ, 1962:455–76.Google Scholar
  25. 25.
    Hennerici M, Albrecht A, Sandmann W, Freund HJ. Incidence of asymptomatic extracranial arterial disease. Stroke 1981;12:750–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Asinger R, Dyken M, Fisher M, Hart RG, Sherman DG. Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol 1989;46:727–43.CrossRefGoogle Scholar
  27. 27.
    Barnett HJM. Heart in ischemic stroke—a changing emphasis. Neurol Clin 1983;1:291–314.PubMedGoogle Scholar
  28. 28.
    Calandre L, Gomara S, Bermejo F, Millan J, Del Pozo G. Clinical-CT correlations in TIA, RIND, and strokes with minimum residuum. Stroke 1984;15:663–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Mohr JP, Caplan L, Melski J, et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978;28:754–62.PubMedCrossRefGoogle Scholar
  30. 30.
    Fisher M. Occlusion of the internal carotid artery. AMA Arch Neurol Psychiatry 1951;65:346–77.PubMedCrossRefGoogle Scholar
  31. 31.
    Stehbens WE. Thrombosis, embolism, infarction, and vascular insufficiency. In: Pathology of the cerebral vessels. St. Louis: Mosby, 1972:131–200.Google Scholar
  32. 32.
    Hacke W, Hennerici M, Gelmers HJ, Kramer G. Cerebral ischemia. New York: Springer-Verlag, 1991.CrossRefGoogle Scholar
  33. 33.
    Cole FM, Yates PO. The occurrence and significance of intracerebral micro-aneurysms. J Pathol Bacteriol 1967;93:393–411.PubMedCrossRefGoogle Scholar
  34. 34.
    Wolf P, Kannel W, Verter J. Current status of risk factors for stroke. Neurol Clin 1983;1:317–43.PubMedGoogle Scholar
  35. 35.
    McCormick W, Rosenfield D. Massive brain hemorrhage: a review of 144 cases and an examination of their causes. Stroke 1973;4: 946–54.PubMedCrossRefGoogle Scholar
  36. 36.
    Furlan A, Whisnant J, Elveback L. The decreasing incidence of primary intracerebral hemorrhage: a population study. Ann Neurol 1979;5:367–73.PubMedCrossRefGoogle Scholar
  37. 37.
    Vinters H, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983;14:924–28.PubMedCrossRefGoogle Scholar
  38. 38.
    Wolf P, Kannel W, Verter J. Current status of risk factors for stroke. Neurol Clin 1983;1:317–43.PubMedGoogle Scholar
  39. 39.
    Sahs A, Perret G, Locksley H, Nishioka H. Intracranial aneurysms and subarachnoid hemorrhage. Philadelphia: Lippincott, 1969.Google Scholar
  40. 40.
    Okawara SH. Warning signs prior to rupture of an intracranial aneurysm. J Neurosurg 1973;38:575–80.PubMedCrossRefGoogle Scholar
  41. 41.
    Roach ES, Garcia JC, McLean W. Cerebrovascular disease in children. Am Fam Physician 1984;30:215–25.PubMedGoogle Scholar
  42. 42.
    Solomon G. Strokes in children. Pediatr Neurol 1978;7:813–25.Google Scholar
  43. 43.
    Golden G. Strokes in children and adolescents. Stroke 1977; 9:169–71.CrossRefGoogle Scholar
  44. 44.
    Matson D. Intracranial arterial aneurysms in childhood. J Neurosurg 1965;23:578–83.PubMedCrossRefGoogle Scholar
  45. 45.
    Heyman A. Risk of stroke in asymptomatic persons with cervical arterial bruits. N Engl J Med 1980;4:838–41.CrossRefGoogle Scholar
  46. 46.
    Norris J, Hachinski V Prevention of stroke. New York: Springer-Verlag, 1991.Google Scholar
  47. 47.
    Chambers BR, Norris JW. Clinical significance of asymptomatic neck bruits. Neurology 1985;35:742–745.PubMedCrossRefGoogle Scholar
  48. 48.
    Ingall T, Homer D, Whisnant J, Baker HL, O’Fallon WM. Predictive value of carotid bruit for carotid atherosclerosis. Arch Neurol 1989;46:418–422.PubMedCrossRefGoogle Scholar
  49. 49.
    Howard V. Correlation of carotid bruits and carotid atherosclerosis detected by B-mode real-time ultrasonography. Stroke 1989;20: 1331–5.PubMedCrossRefGoogle Scholar
  50. 50.
    Ruff R, Dougherty J. Evaluation of acute cerebral ischemia for anticoagulant therapy: computed tomography or lumbar puncture. Neurology 1981;31:736–40.PubMedCrossRefGoogle Scholar
  51. 51.
    Kertesz A, Black S, Nicholson L, Carr T. The sensitivity and specificity of MRI in stroke. Neurology 1987;37:1580–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Ramadan N, Deveshwar R, Levine S. Magnetic resonance and clinical cerebrovascular disease. Stroke 1989;20:1279–83.PubMedCrossRefGoogle Scholar
  53. 53.
    Silver F, Norris JW, Lewis A, Hachinski V. Early mortality following stroke: a prospective review. Stroke 1984; 15:492–496.PubMedCrossRefGoogle Scholar
  54. 54.
    Biller J, Asconape JJ, Barton JS, et al. Poststroke seizures in the elderly. Clin Geriatr Med 1991;7:483–92.Google Scholar
  55. 55.
    Bayer A, Pathy MSJ, Newcombe R. Double blind randomised trial of intravenous glycerol in acute stroke. Lancet 1987;i:405–7.CrossRefGoogle Scholar
  56. 56.
    Weksler B, Lewin M. Anticoagulation in cerebral ischemia. Stroke 1983;14:658–63.PubMedCrossRefGoogle Scholar
  57. 57.
    Scheinberg P. Heparin anticoagulation. Stroke 1989;20:173–4.PubMedCrossRefGoogle Scholar
  58. 58.
    Yatsu F, Hart R, Mohr J, Grotta J. Anticoagulation of embolic strokes of cardiac origin: an update. Neurology 1988;38:314–16.PubMedCrossRefGoogle Scholar
  59. 59.
    Acheson J, Archibald D, Barnett H, et al. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988; 296:320–31.CrossRefGoogle Scholar
  60. 60.
    Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;i:1215–20.CrossRefGoogle Scholar
  61. 61.
    Hass W, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Roederer GO, Langlois YE, Jager KA, et al. The natural history of carotid arterial disease in asymptomatic patients with cervical bruits. Stroke 1984;15:605–13.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Melvina L. McCabe

There are no affiliations available

Personalised recommendations